SUBSCRIBE
SUBSCRIBE
News   Drug Development

Schering-Plough Corporation Suspends One of Five Pharmacopeia Drug Discovery Partnered Clinical Development Programs

August 14, 2007 | 
1 min read
NEW YORK (AP) -- Drug developer Pharmacopeia Drug Discovery Inc. says Schering-Plough Corp. is suspending development of a clinical compound for a metabolic disease, according to a filing with the Securities and Exchange Commission.
Preclinical
MORE ON THIS TOPIC
Electricity saving, ecology awareness or reduce electric cost and expense concept, man pulling electric cord to unplug to save money or for ecology power.
Parkinson’s disease
Biogen, Denali pull plug on Parkinson’s program after mid-stage flop
May 22, 2026
 · 
2 min read
 · 
Tristan Manalac
Crowd silhouettes reach toward a raised trophy beneath a vivid sunset sky, showing shared ambition, victory, teamwork, celebration, and success with open space for text.
Weight loss
Lilly’s triple agonist shows bariatric surgery–like weight loss results
May 21, 2026
 · 
3 min read
 · 
Annalee Armstrong
Fight versus pop art comic red blue background with halftone, rays, hands holding paper. Vector cartoon illustration in retro style. Design for comic book, poster, banner, competition
Leadership
Vaxart seeks shareholder support as battle over stock split brews
May 21, 2026
 · 
2 min read
 · 
Tristan Manalac
Stock market rebound, overcome business down fall and grow up profit or leadership and achievement concept, businessman jump bouncing high on trampoline with green rising up performance arrow graph.
Rare diseases
BioMarin bounces back as Voxzogo performs ‘bigger than expected’ in new indication
May 21, 2026
 · 
2 min read
 · 
Tristan Manalac